Relative cerebral blood volume as response predictor in the treatment of recurrent glioblastoma with anti-angiogenic therapy.
Breda-Yepes M, Rodríguez-Hernández LA, Gómez-Figueroa E, Mondragón-Soto MG, Arellano-Flores G, Hernández-Hernández A, Rodríguez-Rubio HA, Martínez P, Reyes-Moreno I, Álvaro-Heredia JA, Gutiérrez Aceves GA, Villanueva-Castro E, Sangrador-Deitos MV, Alonso-Vanegas M, Guerrero-Juárez V, González-Aguilar A.
Breda-Yepes M, et al. Among authors: gonzalez aguilar a.
Clin Neurol Neurosurg. 2023 Oct;233:107904. doi: 10.1016/j.clineuro.2023.107904. Epub 2023 Jul 17.
Clin Neurol Neurosurg. 2023.
PMID: 37499302